ARCHIVE

• Aiming at Drug Sales of \320 Billion in 2004: Mr Bootes of Pfizer
  March 19, 2001

• Videx Cap. Included in NHI Price List on Emergency Basis
  March 19, 2001

• JPA to Conduct Survey of Endocrine Disruptors
  March 19, 2001

• Generics Approved by March 15 to Be Given NHI Prices in July
  March 19, 2001

• JPMA to Prepare Guidebooks on New PMS Requirements
  March 19, 2001

• LDP Intends to Deal with NHI Prices at First
  March 19, 2001

• Kyowa Hakko Aims at Peak Sales of \20 Bil. for Allelock
  March 19, 2001

• Need for Self-sufficient Blood Supply System Stressed Again: Red Cross Symposium
  March 19, 2001

• Korosho to Promote Studies to Set Pediatric Doses
  March 19, 2001

• Chuikyo Approves 3 New Advanced Medical Technologies
  March 19, 2001

• Control Achieved in More than 65% of RA Patients in Long-term Outpatient Care: RDIC Seminar
  March 19, 2001

• Notification Issued on ICH Stability Test Guidelines
  March 19, 2001

• Significance of Genomic Base Sequence Other than Gene Code Should Be Studied: Prof. Shimizu
  March 19, 2001

• REGULATORY NEWS IN BRIEF -1-
  March 19, 2001

• PMSB to Issue Notification on Safety Management of Medical Radiation
  March 19, 2001

• OTC NEWS IN BRIEF
  March 12, 2001

• Nicorette Reexamined, 2 New Orphan Drugs Designated
  March 12, 2001

• Sankyo Aims at \1 Trillion Sales in FY2010: President Takato
  March 12, 2001

• Q&A Booklet on New PMS for 6 Months after Launching Issued
  March 12, 2001

• MTP Ties Up with Sumitomo, MedGene Regarding HGF
  March 12, 2001

ページ

• « 先頭
• ‹ Prev
• …
• 769
• 770
• 771
• 772
• 773
• 774
• 775
• 776
• 777
• …
• Next ›
• 最終 »